Ajmalicine
CAS: 483-04-5
Ref. 5G-82463
| 25mg | 177.00 € | ||
| 50mg | 319.00 € | ||
| 250mg | 1,363.00 € | ||
| 500mg | 2,564.00 € | ||
| 1000mg | 4,808.00 € |
Estimated delivery in United States, on Tuesday 17 Dec 2024
Product Information
Name:
Ajmalicine
Synonyms:
- Circolene
- Raubasine
- Tetrahydroserpentine
- Vincaine
- Vinceine
- 4H-Indolo[2,3-a]pyrano[3,4-g]quinolizine, oxayohimban-16-carboxylic acid deriv.
- 4H-Indolo[2,3-a]pyrano[3,4-g]quinolizine-1-carboxylic acid, 4a,5,7,8,13,13b,14,14a-octahydro-4-methyl-, methyl ester, (4S,4aR,13bS,14aS)-
- Ajmalicin
- Hydrosarpan
- Isoarteril
- See more synonyms
- Lamuran
- Methyl (19Alpha)-19-Methyl-16,17-Didehydro-18-Oxayohimban-16-Carboxylate
- Methyl 19-Methyl-16,17-Didehydro-18-Oxayohimban-16-Carboxylate
- NSC 72133
- NSC 95087
- Oxayohimban-16-carboxylic acid, 16,17-didehydro-19-methyl-, methyl ester, (19α)-
- Py-tetrahydroserpentine
- Ranitol
- Raubaserp
- Raubasil
- Raubasin
- Raumalina
- Rauvasan
- Sarpan
- Tensyl
- Vincain
- Vincein
- δ-Yohimbine
Description:
Natural alkaloid
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Phytolab
Long term storage:
Notes:
Chemical properties
Molecular weight:
352.43
Formula:
C21H24N2O3
Purity:
≥ 98.0 % (HPLC)
Color/Form:
Powder
InChI:
InChI=1S/C21H24N2O3/c1-12-16-10-23-8-7-14-13-5-3-4-6-18(13)22-20(14)19(23)9-15(16)17(11-26-12)21(24)25-2/h3-6,11-12,15-16,19,22H,7-10H2,1-2H3/t12-,15-,16?,19-/m0/s1
InChI key:
InChIKey=GRTOGORTSDXSFK-JCIYXNMLSA-N
SMILES:
COC(=O)C1=CO[C@@H](C)C2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: 5G-82463 Ajmalicine
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
